Alpha 2.0
Login Register
» Authors » N Boissel

N Boissel

Explore the profile of N Boissel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 779
Followers 0
Related Specialties
Oncology
Hematology
General Surgery
Top 10 Co-Authors
H Dombret
E Raffoux
C Preudhomme
P Fenaux
C Gardin
A Renneville
T Leblanc
X Thomas
P Rousselot
S De Botton
Published In
Leukemia
Ann Oncol
Rev Mal Respir
Bone Marrow Transplant
Int Immunol
Affiliations
Soon will be listed here.
Recent Articles
1.
ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia
Hoelzer D, Bassan R, Boissel N, Roddie C, Ribera J, Jerkeman M
Ann Oncol . 2023 Oct; 35(1):15-28. PMID: 37832649
No abstract available.
2.
Prognostic value of PET/CT and CT in T-cell lymphoblastic lymphoma/leukaemia patients: A retrospective cohort study of 145 patients
Rouzaud C, Vercellino L, De Kerviler E, Raffoux E, Balsat M, Marcais A, et al.
Br J Haematol . 2023 Mar; 201(3):e21-e24. PMID: 36890721
No abstract available.
3.
Corrigendum to 'Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Annals of Oncology Volume 31, Issue 6, June 2020, Pages 697-712]
Heuser M, Ofran Y, Boissel N, Brunet Mauri S, Craddock C, Janssen J, et al.
Ann Oncol . 2021 Apr; 32(6):821. PMID: 33888380
No abstract available.
4.
Efficacy of assisted reproductive technology after ovarian tissue transplantation in a cohort of 11 patients with or without associated infertility factors
Vatel M, Torre A, Paillusson B, Scheffler F, Bergere M, Benkhalifa M, et al.
J Assist Reprod Genet . 2021 Jan; 38(2):503-511. PMID: 33389379
Purpose: IVF treatment in women with grafted frozen-thawed ovarian tissue is associated with poor reproductive outcomes. The aim of this study was to evaluate the efficacy of ovarian tissue transplantation...
5.
Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Heuser M, Ofran Y, Boissel N, Brunet Mauri S, Craddock C, Janssen J, et al.
Ann Oncol . 2020 Mar; 31(6):697-712. PMID: 32171751
No abstract available.
6.
Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation
Poirot C, Fortin A, Lacorte J, Akakpo J, Genestie C, Vernant J, et al.
Hum Reprod . 2019 May; 34(6):1083-1094. PMID: 31116405
Study Question: How efficacious is transplantation of ovarian cortex previously exposed to chemotherapy? Summary Answer: Prior exposure to chemotherapy did not disrupt the function of cryopreserved ovarian tissue after transplantation....
7.
TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome
Villarese P, Lours C, Trinquand A, Le Noir S, Belhocine M, Lhermitte L, et al.
Leukemia . 2017 Jun; 32(1):61-71. PMID: 28592888
T-cell acute lymphoblastic leukemia (T-ALL) results from leukemic transformation of T-cell precursors arrested at specific differentiation stages, including an 'early-cortical' thymic maturation arrest characterized by expression of cytoplasmic TCRβ but...
8.
Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia
Antony-Debre I, Duployez N, Bucci M, Geffroy S, Micol J, Renneville A, et al.
Leukemia . 2015 Aug; 30(4):999-1002. PMID: 26316320
No abstract available.
9.
Usefulness of the 2012 European CVD risk assessment model to identify patients at high risk of cardiovascular events during nilotinib therapy in chronic myeloid leukemia
Rea D, Mirault T, Raffoux E, Boissel N, Andreoli A, Rousselot P, et al.
Leukemia . 2014 Dec; 29(5):1206-9. PMID: 25482133
No abstract available.
10.
Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML
Sebert M, Porcher R, Robin M, Ades L, Boissel N, Raffoux E, et al.
Bone Marrow Transplant . 2014 Sep; 50(1):74-81. PMID: 25243624
Allogeneic hematopoietic stem cell transplantation provides the best chance of long-term survival for patients with AML, but is associated with an unpredictable risk of treatment-related mortality. From January 2000 to...